...
首页> 外文期刊>Circulation journal >Can Tolvaptan Protect Renal Function in the Early Postoperative Period of Cardiac Surgery? - Results of a Single-Center Randomized Controlled Study -
【24h】

Can Tolvaptan Protect Renal Function in the Early Postoperative Period of Cardiac Surgery? - Results of a Single-Center Randomized Controlled Study -

机译:托洛瓦班可以在心脏病术后早期保护肾功能吗? - 单中心随机对照研究的结果 -

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Background: Oral administration of tolvaptan, a vasopressin V-2 receptor antagonist, significantly reduces deterioration of renal function, which has recently been highlighted as an exacerbating factor for adverse events in patients with acute heart failure. In the present study we tested the hypothesis that concomitant administration of tolvaptan with a conventional diuretic is beneficial for perioperative body fluid management in patients who have undergone cardiac surgery.
机译:背景:罗瓦膜素V-2受体拮抗剂的口服施用显着降低了肾功能的恶化,这最近被突出为急性心力衰竭患者不良事件的加剧因素。 在本研究中,我们测试了一种假设,即伴随着常规利尿剂的罗瓦膜施用对患者的围手术期体液管理有利于心脏手术。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号